BlaDiMir
BlaDiMir is an in vitro diagnostic system for detecting bladder cancer in urine through the measurement of specific microRNAs. It uses quantitative PCR (qPCR) technology to provide a precise and non-invasive diagnosis, improving accuracy and reducing the need for invasive procedures such as cystoscopy.
BlaDiMir+ not only focuses on detecting bladder cancer but also on predicting the response to Bacillus Calmette-Guérin (BCG) treatment, which is a standard therapy for non-muscle invasive bladder cancer (NMIBC).
BlaDiMir+